annual review and summarized accounts 2009€¦ · annual review, the decision was taken at the end...

ANNUAL REVIEW 2009 | 1

Annual Review and Summarized Accounts 2009

2 | ANNUAL REVIEW 2009

Front cover photos from left 1-3, and images on pages 12 and 16, supplied courtesy of AstraZeneca.

Front cover photo Embryonic stem cell, courtesy of Nissim Benvenisty.


Contents3 British Pharmacological Society Mission

4 President and Chief Executive’s review

6 2009 Objectives

7 2009 Achievements

8 Awards and prizes

11 Membership

12 Scientificmeetings

15 Selected symposia and lectures

16 Education and training

20 External affairs

24 Publications

27 Structure, governance and management

28 Advisers and Donors

29 Trustees and Executive Committee

30 BPS Staff

31 Financial review

34 Statementoffinancialactivities

35 Balance sheet

36 Objectives for 2010

British Pharmacological Society Mission

The British Pharmacological Society (BPS) is the primary UK learned society concerned with research into drugs and the way they work. Our members work in academia, industry and the health services, and manyaremedicallyqualified.TheSocietycoversthe whole spectrum of pharmacology, including the laboratory, clinical, and toxicological aspects.

The BPS exists to promote and advance pharmacology (including, without limit, clinical pharmacology), and to be the leading Society for the presentation, promotion, and discussion of all matters relating to both pharmacology and clinical pharmacology andtherapeutics(CPT).Specifically,theSocietyis concerned with the discovery, mechanism of action, use, and safety of drugs in humans and animals, in order to contribute to education and the understanding and relief of suffering.

The Society is a registered Charity. The Society’s governing document is its Memorandum, Articles of Association and Rules. In 1994, the Society became a Company Limited by Guarantee.

Registered charity name:

British Pharmacological Society

Charity registration number:

1030623

Company registration number:

2877400

Principal & registered office:

16 Angel Gate, City Road, London EC1V 2PT

Tel: 020 7417 0110


President and Chief Executive’s review

2009 was another year of considerable change and innovation for the BPS. As mentioned in last year’s Annual Review, the decision was taken at the end of 2008 to place the BJP and BJCP with a single publisher, Wiley Blackwell, and to transfer the BJP Editorial Officetothepublishers,awayfromAngelGate.

It was also agreed to restructure the BPS secretariat around four key functional areas: Education, Meetings, Communication, and Development, to ensure that theofficestaffwereappropriatelyqualifiedtodrive implementation of our ambitious strategy.

This was a time-consuming, and at times stressful, process, which for a period over the summer involved running operations with a much reduced staff complement.However,weareconfidentthattheBPSofficeisnowbetterplacedtomeetthechallengesahead, and we are grateful to all members of the BPS team for pulling together so well during this difficulttransitionalperiod.Thelistofcurrentstaffand their respective roles is available on page 30.

We also took the opportunity to undertake a wholesale refurbishmentoftheBPSoffices,toprovideimprovedservices for members and employees. Staff are nowconcentratedontwofloors(ratherthanbeingdispersedoverfourfloorsasbefore)inanopen-planlayout, which encourages interaction and team-work.

We have installed a shower, to encourage cycling and walking to work. A conference room facility has been introduced, which means that we can hold all of our committee meetings in-house, saving on the costs of external room hire, and will host events

such as Diploma workshops, focused meetings, and the Women in Leadership seminar in 2010.

We are in the process of developing a library facility, which will incorporate a rotating archive display and a hot-desking facility, which is already proving a popular base for BPS members when in London. This, as well as the conference facilities mentioned above, is available free of charge to members.

In spite of this disruption, we still managed to deliver against the key objectives set for the year, and more details of these achievements can be found on page 7, and in the reports of individual BPS functions.

Innovations during the year included our entry into the world of social networking. By the end of the year we had 187 followers on Twitter and 230 fans on Facebook, and this number continues to rise.

With the appointment of Jonathan Brüün as Head of Communications and Development, we have been able to develop a far more proactive approach to press coverage, and we are now regularly asked by news agencies to contribute opinions as stories with a pharmacological orientation arise.SessionsattheWinterMeetingwerefilmedforthefirsttime,andareaccessibleviaourYouTube channel and on the BPS website.

We were delighted to see the increases in impact factors of both journals, to 4.902 for BJP and 3.128 for BJCP.

Inadditiontoitscorescientificmeetingsandeducational activities, BPS continued to be

Kate Baillie - Chief Executive

Jeff Aronson - President


represented at a wide range of careers fairs and events, designed to raise public awareness about pharmacology. Following on from the success of the firstBPSsponsoredsessionattheCheltenhamScienceFestival last year, Professor Clive Page hosted a session on the ‘Science of Curry’, which proved extremely popular. This session will be developed into a travelling roadshow in 2010, with funding from the Department of Business Innovation and Skills as part of their ‘Science: So What? (So Everything)’ campaign. BPS also sponsored a session on supplements at the British Science Festival and produced a booklet, Biology in the Real World, Bringing the Curriculum to Life, for the Association of Science Educators Annual Conference.

The BPS continued to forge links with a number of other Societies. Talks to establish closer links with the British Toxicology Society took place, and there are now plans for joint meetings and educational activities, as well as reciprocal articles in each Society’s newsletter.

Activities to ensure the renaissance of clinical pharmacology continued to be a major focus for BPS in 2009. Among many other activities, we participated in the RCP Medicines Forum, established as a result of the RCP’s 2009 report Innovating for Health: Patients, Physicians, the Pharmaceutical Industry and the NHS, and several members were also actively involvedintheTaskandFinishgroupsoftheOfficeforLife Sciences’ joint Industry/Higher Education Forum focusing on Clinical Pharmacology and in vivo sciences, formed as a result of its Life Sciences Blueprint. A complete account of all relevant developments during 2006-9 has been published in BJCP (2010;69(2):111-7).

A joint session on diabetes was held at the British Pharmaceutical Conference, and strong support was given to the EACPT meeting in Edinburgh, including sponsorship of two key symposia on Prescribing and Hypertension. A clinically-themed issue of Pharmacology Matters was also produced to coincide with the conference and copies were inserted into each delegate’s bag.

Development work also continued with the joint BPS/E-learning for Health initiative, Prescribe, which aims to introduce safe prescribing skills into the core learning of every medical undergraduate.

Attheendof2009,thefollowingofficerscompletedtheirtermofoffice:ProfessorCherryWainwright; Professor Robin Plevin; Professor Sue Brain (Vice President Academic Development); Dr Martin Todd; Dr Kim Dora; Professor Peter Roberts (Chair of CHOP); and Professor Phil Routledge. Both Martin and Phil will continue to serve as members of the Executive Committee, respectively representing industry and as President-elect.

We are grateful to them, and indeed to all the Society’sofficers,forvolunteeringconsiderableamounts of unpaid time to contribute to the effective governance and continued development of the BPS.

Jeff Aronson MA MBChB DPhil FRCP FBPharmacolS FFPM (Hon)

Kate Baillie MA MBA

Our thanks to JeffWe would like to acknowledge the enormous contribution that Jeff Aronson has made to BPS during his term as President-elect and then President. In those four years, Jeff has ensured that clinical pharmacology issues have been highlighted at UK national level and that the contribution of pharmacology and clinical pharmacology to the health of the nation has been more clearly recognized. As a Society we hope to continue to build upon the strong foundation that Jeff has established, particularly in the areas of safe and rational prescribing.

Ray Hill BPharm PhD DSc (Hon) FBPharmacol FMedSci President

Phil Routledge OBE MD FRCP FRCPE FBTS President-elect


Our objectives• Promulgateexcellentscientificresearchbyrunningprogrammesofhigh-qualityscientificmeetingsandeducationalcourses,includingcollaborationwithotherSocieties. • InresponsetothistheBPSwelcomedover1700delegates,includingover900BPSmembers,toaprogrammeofscientificmeetingsin2009.Themeetingsvariedfromfocused,JamesBlackandannual

meetings, to supporting large conferences and sponsored symposia both individually and in conjunction with other societies

• Develop a new website in conjunction with the Society’s journals, British Journal of Pharmacology and British Journal of Clinical Pharmacology, to generate an over-arching pharmacology portal to promote pharmacology and clinical pharmacology to existing and potential members, other professional groups, and the general public, including school students, teachers and science communicators.

• Following a period of ‘best practice’ benchmarking, and after consultation with the Society’s committees, a new website design was approved and commissioned in late 2009• The site is being built by our publishers, Wiley Blackwell, and will highlight key areas of our work – Pharmacology and Clinical Pharmacology, Meetings, Publications and Education, including

pharmacological careers – on its home page• Our new website will include web 2.0 functionality, enabling members to form online networking groups, discuss hot topics and search online archives of BPS resources• In addition, we developed a number of external social networking sites such as Facebook and Twitter, reaching out to audiences beyond our existing membership. By the end of 2009, our combined

social networking membership-base ran at around 500 users, and growth was being measured at between 3 and 5 new members per day

• Develop and deliver high-quality Diploma workshops; maintain a presence at undergraduate/careers fairs and teachers’ conferences; use the enhanced web presence to promote education, especially in integrative Pharmacology.

• BPS ran six workshops during 2009, attracting 120 attendees, 66 of whom were registered for the Diploma in Advanced Pharmacology• We also exhibited, with other Biosciences Federation member organizations, at several careers fairs, including two UCAS fairs, and the SOURCE event organized by Nature Jobs. We maintained our

presenceattheannualmeetingoftheAssociationforScienceEducation(ASE),theCheltenhamScienceFestival,andforthefirsttimerananeventattheBritishScienceFestival• The BPS contributed a further three practicals to the Practical Biology online resource during 2009, bringing the total to six pharmacological practicals featured on this valuable teaching resource• We also made use of social networking sites, the website and e-bulletin to promote our events, prizes, and extensive integrative pharmacology training opportunities

• RestructuretheBPSsecretariattodeliverservicestomembersandbroaderstakeholdergroupsasefficientlyandeffectivelyaspossible. • ThetransferoftheBJPeditorialofficetoWiley-BlackwellprovidedtheBPSwithanopportunitytorestructurethesecretariatduring2009.Therestructurecentredonourfourkeyfunctionalareas:education,meetings,communication,anddevelopment.Theofficenowoperateswith10membersofstaff,70%ofwhicharegraduates,whichcomparesfavourablywiththe33%pre-restructure.Finalappointments to the Angel Gate team will be made during 2010

• Work with the Department of Health’s E - Learning for Health Initiative to develop Prescribe, a web based training tool to inculcate safe prescribing principles in undergraduate medical students. • The BPS continued to collaborate with the Department of Health on the Prescribe initiative during 2009, and was represented at Prescribe Executive meetings • Around30e-learningsessionswerecommissionedoverthecourseof2009,10%ofthetotalnumberneededoverthelifespanoftheproject.Inaddition,theSocietybeganworktoinclude14modules

fromourPharmaCALogye-learningsuiteaspartofanextendedlearningareathePrescribecurriculum.Thesemoduleswillbeofferedasabenefittothe38,000medicalstudentswhotraininthe UK annually

• Raisetheprofileofpharmacologyandclinicalpharmacologybyrespondingtogovernmentandotheragencyconsultationsandworkinginconjunctionwithotherlearnedsocietieswhenappropriate. • We responded to 12 consultations during 2009, jointly with other learned societies including the Institute of Biology, and the Biosciences Federation on four occasions. A full consultations list can be found on page 21

• Use the synergies generated by the move to a single publisher for BJP and BJCP to optimise their coverage of the spectrum of pharmacology and clinical pharmacology from molecule to society. • Since January 2009 both journals have been published by Wiley-Blackwell. This move has created an opportunity for the journals to expand their respective coverage to encapsulate the whole spectrum of pharmacology. The journals have already published a virtual themed issue and will continue to look for innovative ways to strengthen the relationship between the sister journals during 2010

• Enhance communication with members and other stakeholders via regular issues of Pharmacology Matters, highlighting topical issues and themed issues that will attract potential new members. • The monthly e-bulletin, Pharmacology Matters, and the success of new channels of communication such as our social networking sites, have provided us with an opportunity to engage with an audience beyond our membership

• Our in-house magazine, also called Pharmacology Matters, is now routinely sent to 20 university pharmacy departments in the UK and during 2010 we will look to other relevant groups to increase the distribution


Our achievements• Promulgateexcellentscientificresearchbyrunningprogrammesofhigh-qualityscientificmeetingsandeducationalcourses,includingcollaborationwithotherSocieties. • InresponsetothistheBPSwelcomedover1700delegates,includingover900BPSmembers,toaprogrammeofscientificmeetingsin2009.Themeetingsvariedfromfocused,JamesBlackandannual

meetings, to supporting large conferences and sponsored symposia both individually and in conjunction with other societies

• Develop a new website in conjunction with the Society’s journals, British Journal of Pharmacology and British Journal of Clinical Pharmacology, to generate an over-arching pharmacology portal to promote pharmacology and clinical pharmacology to existing and potential members, other professional groups, and the general public, including school students, teachers and science communicators.

• Following a period of ‘best practice’ benchmarking, and after consultation with the Society’s committees, a new website design was approved and commissioned in late 2009• The site is being built by our publishers, Wiley Blackwell, and will highlight key areas of our work – Pharmacology and Clinical Pharmacology, Meetings, Publications and Education, including

pharmacological careers – on its home page• Our new website will include web 2.0 functionality, enabling members to form online networking groups, discuss hot topics and search online archives of BPS resources• In addition, we developed a number of external social networking sites such as Facebook and Twitter, reaching out to audiences beyond our existing membership. By the end of 2009, our combined

social networking membership-base ran at around 500 users, and growth was being measured at between 3 and 5 new members per day

• Develop and deliver high-quality Diploma workshops; maintain a presence at undergraduate/careers fairs and teachers’ conferences; use the enhanced web presence to promote education, especially in integrative Pharmacology.

• BPS ran six workshops during 2009, attracting 120 attendees, 66 of whom were registered for the Diploma in Advanced Pharmacology• We also exhibited, with other Biosciences Federation member organizations, at several careers fairs, including two UCAS fairs, and the SOURCE event organized by Nature Jobs. We maintained our

presenceattheannualmeetingoftheAssociationforScienceEducation(ASE),theCheltenhamScienceFestival,andforthefirsttimerananeventattheBritishScienceFestival• The BPS contributed a further three practicals to the Practical Biology online resource during 2009, bringing the total to six pharmacological practicals featured on this valuable teaching resource• We also made use of social networking sites, the website and e-bulletin to promote our events, prizes, and extensive integrative pharmacology training opportunities

• RestructuretheBPSsecretariattodeliverservicestomembersandbroaderstakeholdergroupsasefficientlyandeffectivelyaspossible. • ThetransferoftheBJPeditorialofficetoWiley-BlackwellprovidedtheBPSwithanopportunitytorestructurethesecretariatduring2009.Therestructurecentredonourfourkeyfunctionalareas:education,meetings,communication,anddevelopment.Theofficenowoperateswith10membersofstaff,70%ofwhicharegraduates,whichcomparesfavourablywiththe33%pre-restructure.Finalappointments to the Angel Gate team will be made during 2010

• Work with the Department of Health’s E - Learning for Health Initiative to develop Prescribe, a web based training tool to inculcate safe prescribing principles in undergraduate medical students. • The BPS continued to collaborate with the Department of Health on the Prescribe initiative during 2009, and was represented at Prescribe Executive meetings • Around30e-learningsessionswerecommissionedoverthecourseof2009,10%ofthetotalnumberneededoverthelifespanoftheproject.Inaddition,theSocietybeganworktoinclude14modules

fromourPharmaCALogye-learningsuiteaspartofanextendedlearningareathePrescribecurriculum.Thesemoduleswillbeofferedasabenefittothe38,000medicalstudentswhotraininthe UK annually

• Raisetheprofileofpharmacologyandclinicalpharmacologybyrespondingtogovernmentandotheragencyconsultationsandworkinginconjunctionwithotherlearnedsocietieswhenappropriate. • We responded to 12 consultations during 2009, jointly with other learned societies including the Institute of Biology, and the Biosciences Federation on four occasions. A full consultations list can be found on page 21

• Use the synergies generated by the move to a single publisher for BJP and BJCP to optimise their coverage of the spectrum of pharmacology and clinical pharmacology from molecule to society. • Since January 2009 both journals have been published by Wiley-Blackwell. This move has created an opportunity for the journals to expand their respective coverage to encapsulate the whole spectrum of pharmacology. The journals have already published a virtual themed issue and will continue to look for innovative ways to strengthen the relationship between the sister journals during 2010

• Enhance communication with members and other stakeholders via regular issues of Pharmacology Matters, highlighting topical issues and themed issues that will attract potential new members. • The monthly e-bulletin, Pharmacology Matters, and the success of new channels of communication such as our social networking sites, have provided us with an opportunity to engage with an audience beyond our membership

• Our in-house magazine, also called Pharmacology Matters, is now routinely sent to 20 university pharmacy departments in the UK and during 2010 we will look to other relevant groups to increase the distribution


Our 2009 prize winners


BPS prizes and awards

2009 Science, Engineering & Technology (SET) Student of the Year Awards Winner of the Pharmacology Category: Yiwen Dong

Wellcome Gold Medal Professor Gus Born

Rang Prize Dr Alan Gibson and Professor Simon Maxwell

J R Vane Medal Professor Christopher Garland

Novartis Prize Dr Jillian Baker

Aptuit Prize Dr Christopher Stevenson

AJ Clark Studentship Alexandra Cooke

The BPS offers a variety of prizes and awards; here are our 2009 winners, congratulations to all of them:

ASIF Awards: Vacation Studentships Mai Khidir

Lina Kobayter

Alice Neffendorf

Nathaniel Lee

Deborah Clarke

James Hall

Schachter Award Khalil El Deeb

Shruti Parikh

AstraZeneca Prize for Women in Pharmacology Professor Julia Buckingham

Lilly Prize ProfessorMarkCaulfield

Bill Bowman Travelling Lectureship Dr Alister McNeish and Dr Stephen Briddon

Winter Meeting 2009 Prizes:

ThePfizerCPSPosterPrize Nithya Devadoss

The GlaxoSmithKline Prize for CPS Oral Communications Dr Vikas Kapil

BJCP Young Investigators Prize 2009 Jointly awarded to Birgit Koch and James Oliver


Clinical Pharmacology Section 2009 prize winnersAnnual prizes for medical students nominated by their medical schools as the best students in clinical pharmacology or in clinically-related pharmacology. Congratulations to all our 2009 winners:

Examination

University of Birmingham n Victoria Bargate, Lucinda Hiam

University College Cork n Dearbhla Marie Kelly

Barts and the London Medical School, Queen Mary University of London n Thomas Barber

King’s College London n Siobhan Cleary

Imperial College n Mark Andrew Peterzan

St. George’s n Samuel Raveney

University of Nottingham n Helen Bauer, Graham Sharrock

Peninsula Medical School n Lucinda Gunn and Susan Smith Rayne Institute, UCL n Neal James Russell, Nirupa Desai

University of Warwick n Rhodri Handslip and Katie Kirton

Research Project Report

University of Aberdeen n Gordon Blair

University of East Anglia n Hannah Pintilie

University of Glasgow n Matthew Wilson

University of Liverpool n Simon A Bird, Hamira Ul-Haque

King’s College London n Maryam Subhan

Barts and the London Medical School, Queen Mary University of London n Sheiva Rose Maleki Toyserkani and Sheena Vinoobhai Patel

Rayne Institute, UCL n Carolina Lahmann

University of Manchester n Elizabeth PS Reuben

Queen’s University Belfast n Ellen Gorman, Anne-Marie Beirne

University of Oxford n Charles McFadye

University of Southampton n Chris Abbosh, Sarah Nickerson

Cardiff University n Cherry Shute

Special Study Module Report

University of Edinburgh n Paul McCaughey, Kyle Gibson

Newcastle University n Albert Zishen Lim

BPS Prizes for Clinical Pharmacology 2010

National prizes for best poster:

1) Kyle Gibson

2) Christopher Abbosh

3) Sheiva Maleki-Toyserkani


MembershipThe total BPS membership on 31 December 2009 was 2590. There were 865 members of the Clinical Pharmacology Section, of whom 303 are undergraduate or postgraduate Associate members. In December 2009 the AGM elected 8 new Honorary Fellows.

One new Fellow, 72 new members, and 319 new Associate members (including undergraduate and postgraduate students) were elected during the year.

The deaths of eight members were reported.

101

1,237

112

328

363

68 381 Fellows

Members

Associates

Postgraduates

Undergraduates

Honorary Fellows

AeBred Members

101

1,237

112

328

363

68 381 Fellows

Members

Associates

Postgraduates

Undergraduates

Honorary Fellows

AeBred Members

101

1,237

112

328

363

68 381 Fellows

Members

Associates

Postgraduates

Undergraduates

Honorary Fellows

AeBred Members

319 new associate members (including undergraduate and postgraduate students) were elected during the year.


There was a greater focus on networking at the 2009 winter meeting


Scientificmeetings5-6 February 2009, Ion Channels as Therapeutic Targets, Novartis Horsham Research Centre 158 attendees Jointly organized with the Royal Society of Chemistry (RSC) by Dr Ian McFadzean. The meeting encouragedcommunicationandscientificinteractionbetween biologists and medicinal chemists, with a particular focus on channels that offer potential as targets for therapeutic intervention.

21-21 April 2009, 3rd Focused Meeting “Cell Signalling”, University of Leicester 167 attendees (82 members) Organized by Professor John Challiss and Dr Andrew Tobin. The meeting brought together a broad range of scientists from academia and industry to highlight and discuss the latest developments in signalling. Mixingtalksbyfieldleadersandshorterpresentationsfrom doctoral/post-doctoral researchers, it provided aforumforscientificandsocialinteractionbetweenUK-based academic and industrial scientists.

7-9 May 2009, New Drugs in Cardiovascular Research, Dresden, Germany 200 attendees Jointly organized with the German Societies for Pharmacology and Clinical Pharmacology, this meeting focused in particular on basic cardiovascular research and its translation into clinical drug development. BPS sponsored an EPHAR lecture on ‘Pharmacogenomic approaches

Weaimtosupportandproducealivelyandinterestingprogrammeofscientificmeetings:

in Drug Therapy’ given by Desmond Fitzgerald (University College Dublin, Ireland) and introduced by Professor Eeva Moilanen, President of EPHAR.

14 May 2009, Young Life Sciences 2009, the Council House, Bristol120 attendees Supported by the BPS, in conjunction with the Biochemical Society, the Genetics Society, and The Physiological Society. Focused around the differentdisciplineswithinthefieldofneuroscienceand encompassed three hot topics around the title ‘Neurological disorders: from molecules to medicine’. ‘Young Life Scientists 2009’ provided young scientists with an opportunity to present their work, discuss their research, and network with other scientists working in a similar discipline.

8-10 July 2009, BPS Summer Meeting 2009, University of Edinburgh 294 attendees (184 members)Thescientificmeetingcomprisedamixtureofplenarylectures, specialist symposia, and free communications inawidevarietyoffields.Thiswascomplementedby a range of social events, which allowed members and guests to exchange ideas in an informal setting. The BPS welcomed eight trade exhibitors.

12-15 July 2009, EACPT, Edinburgh International Congress Centre1000 attendees The BPS was actively involved in the organization

Attendees and exhibitors, at the 2009 Winter meeting, fed their experience backviaanonlinesurveyforthefirsttime:

‘Very enjoyable conference. Very good value for money. Lovely conference dinner’

‘A very interesting and enjoyable conference’

‘The level of the scientific programme was excellent’

‘A great way of getting recognition and introducing ourselves to new researchers out there’ Tocris Bioscience


and promotion of EACPT 2009, the 9th biennial international congress of the European Association for Clinical Pharmacology and Therapeutics, which had a major focus on translational medicine.

There was a strong focus on all areas of clinical pharmacology and therapeutics, including symposia on clinical pharmacology in Eastern Europe, clinical pharmacology in the Nordic countries, and a BPS- sponsored symposium on: Clinical pharmacology: Working with patients (organized by Professor Simon Maxwell) and Hypertension (organized by Professor Gordon McInnes).

The EPHAR-sponsored lecture, ‘emerging drugs for the treatment of acute heart failure syndromes’ was given by Professor Juan Tamargo.

25 bursaries of up to £400 each were awarded as a contribution towards travel, registration and accommodation costs. Around 1000 scientists from over 60 different countries (including many from outside Europe) participated in the meeting.

1-3 September 2009, 7th James Black Conference, King’s College London 191 attendees (80 members) Jointly organized with The Physiological Society and supported by a grant from the Integrative Mammalian Biology initiative, funded by the BBSRC, BPS Integrative Pharmacology Fund (donors AstraZeneca, GSKandPfizer),theMRC,HEFCE,SFC,andDIUS.Theconference attracted 100 abstracts.

Each day of the four-day programme was dedicated to a different topic around the subject of ‘Integrative Pharmacology and Physiology: Translating ‘Omics’ into Functional and Clinical Applications’. These areaswere:Pain,inflammationandinjury;Modelsof

cardiovascular and respiratory disease—from bench to bedside; In vivo approaches to studying metabolism; andModelsofimmuno-inflammationandinfection:clinical predictive validity

The conference programme was made up of plenary lectures, short talks from selected abstracts, poster presentations, and panel discussions. The conference also offered delegates an opportunity to network in a social environment during the Conference dinner.

7-10 September 2009, Drug Discovery Symposium, BT Convention Centre, Liverpool1054 attendees Organized in association with ELRIG (European Laboratory and Robotics Interest Group) and SBS (Society of Biomolecular Sciences), this meeting facilitated communication, networking, and education between academic and industrial scientists involved in early-phase drug discovery. There were seven scientificsessionsandonetechnicalworkshop.Duringthe symposium delegates had the opportunity to hear world-class speakers discuss the challenges facing drug discovery scientists.

15-17 December 2009, BPS Winter Meeting 2009, The Queen Elizabeth II Conference Centre, London 680 attendees (546 members)The Winter Meeting 2009 was held in London. In addition to the seven plenary lectures from leading international speakers, there were 10 symposia, seven oral communication sessions, and a wide range of poster presentations.

Following the success of the ‘Young Members’ Day’ in 2008, the Winter Meeting once again dedicated a day to Young Pharmacologists. This included a verypopularscientificsymposiumon‘Translational

pharmacology —optimizing academic/industry partnerships’ and the Tocris Lecture ‘Making sense of science for the public’ presented by Alice Tuff, Development Manager at Sense about Science. In addition to the usual mix of postgraduate students and senior scientists, 29 undergraduate bursaries were awarded, enabling students to present project results at the meeting, gaining valuable experience for their future careers.

Recordings of interviews with keynote speakers continue to be available on the BPS website, and video recordings of some of the meeting presentations can be found on YouTube via BPS TV.

The science was complemented by a selection of social events, which included a Thames River Boat Cruise organized by the Young Pharmacologists and the BPS Annual Dinner and Prize Giving, which was held in the stunning dining room at One Whitehall Place, London.

Resources

BPS meetingshttp://www.bps.ac.uk/article451.asp

BPS TVhttp://www.youtube.com/user/BritPharmSoc


Selected symposia and lectures 2009 saw symposia and lectures delivered across a wide range of subject areas:

Clinical PharmacologyThe President’s Plenary Lecture: Clinical Pharmacology: Past, Present, and (YES) Future (Dr Jeff Aronson)

The President’s [Invited] Lecture:Pharmacological autocompensation (Professor Sir Nicholas Wald)

The GSK prize lecture for research in clinical pharmacology: Applied clinical pharmacology in rural Asia—preventing deaths from organophosphate pesticides (Dr Michael Eddleston)

The many faces of CPT. Specialist Registrars’ Session

Delivering safe prescribing in the NHS

ReceptorsGary Price Memorial Lecture: Ion permeation in pentameric ligand-gated ion channels-beyond transmembrane domain (Professor John Peters)

GPCR signalling: new connections and ligand selectivity

Metabotropic glutamate receptors: advancing novel drugs for treating CNS disorders

AutonomicMSD Lecture: Central 5-HT — hearts, bladders but not minds (Dr Andy Ramage)

EndothelialJR Vane Lecture: Endothelial cells, hyperpolarization and vascular control (Professor Christopher Garland)

Emerging technologies Antibody therapeutics

CannabinoidsTargeting the endocannabinoid system for gastrointestinal diseases

HistamineThe histamine H4 receptor: new multi-use therapeutic target

RespiratoryAptuit Lecture: Insights into the pathogenesis of COPD from preclinical in vivo models(Dr Christopher Stevenson)

Challenges in respiratory disease drug development

Pharmacology at largeASCEPT UK Visitors Lecture: Glucocorticoid-resistant inflammationandtissueremodelling:adriverforanti-inflammatorydrugdiscovery(Professor Alastair Stewart)

Tocris Lecture (nominated by the Young Persons’ Section): Making sense of science for the public(Ms Alice Tuff)

Paton Lecture: The past present and future of pharmacology: successes, failures and threats from managerialism and quackery (Professor David Colquhoun)

Translational pharmacology — optimizing academic/industrial partnerships

Circadian rhythms — pharmacology and therapeutic potential

Peripheral actions of MDMA and other amphetamine derivative drugs of abuse

Alzheimer’s disease — mechanistic insights and novel therapeutics

Chemokine antagonists as therapeutic agents


ApplicationsforUKuniversitieshaverisenby23%comparedwithlastyear.Applicationsforpharmacy,pharmacologyandtoxicologydegreesareupby15.6%. Results of an independent survey carried out by Pharmacist Support www.pharmacistsupport.org


Education and training Our education and training activities form an integral part of the promotion and advancement of pharmacology in the UK:

BPS Diploma in Advanced Pharmacology

40 candidates were registered for the BPS Diploma at the end of 2009, and the Society ran the following six workshops:

• IntegrativePharmacologyWorkshop – 19 attendees (6 non-diploma) (31 March)

• Statistics–19attendees (8 non-diploma) (13 May)

• ApplyingReceptorTheorytoDrugDiscovery – 21 attendees (13 non-diploma) (6 July)

• Pharmacokinetics–20attendees (9 non-diploma) (7 July)

• EarlyPhaseTrialsofNewDrugs – 20 attendees (7 non-diploma) (1 September)

• DrugDiscovery–21attendees (11 non-diploma) (14-15 December)

In addition to the diploma workshops we ran thefollowingspecificallyforPhDstudents:

• Statistics–25attendees(12May)

Forthefirsttimein2009,individualworkshops were actively promoted as being open to everybody, not just those enrolled on the diploma course. This resulted in a 50/50 split between Diploma and non-Diploma participants. Each workshop now receives six CPD points, and there has been anincreaseinclinicallyqualifieddelegates,

Attendee feedback from our educational offerings continued to be positive in 2009:

‘I have gained a great deal of knowledge in receptor pharmacology that helps me interpret data and plan experiments. The course dealt with real practical issues as well as theory’

‘I think the interactive nature – being able to ask questions – was good. The structure of the course is excellent – covering a varied number of topics to a good amount of detail’

‘I thought this workshop was absolutely brilliant! I would most definitely recommend it’

particularly for topics such as pharmacokinetics.

The following students successfully graduated from the Diploma in Advanced Pharmacology in 2009:

Jenni Cryan

Sara Pritchard

Sue Summerhill

Shilina Roman

Educational tools

PharmaCALogy computer assisted learning programsAll PharmCALogy modules will be revised during 2010, and a selection of the modules will be replatformed within the Prescribe e-Learning for Health (e-LfH) initiative.

Prescribe e-Learning for HealthcarePrescribe is being developed by the BPS in collaboration with Prescribe (e-LfH) for students of medicine and related professions. Prescribe will provide e-learning materials for 36,000 medical students to aid their understanding of the principles of basic and clinical pharmacology, which underpin safe and effective prescribing in the NHS.

Prescribe will begin to go live at the end of 2010.

SocietyofBiology/NuffieldCurriculumCentrePracticalBiology websiteThe Practical Biology website contains a number of practical experiments designed for teachers of


secondary school Biology to download and reproduce in the classroom. The BPS has now contributed the following practicals with a bio-medical input:

Modelling the effect of aspirin on blood clots

No stomach for it: investigating antacid metabolism (jointly with Physiological Society)

Investigating factors affecting the heart rate of Daphnia

Modelling the human ventilation system (jointly with Physiological Society)

Promoting women in pharmacology

Leadership Skills for Women - 4 June 2009 Barts & The London Medical School, LondonA one-day pilot workshop, organized by the UK Resource Centre for Women in Science, Engineering and Technology (UKRC), designed to provide women in leadership positions (or those aspiring to them), with a forum for discussion about leadership and networking with peers. The workshop was attended by 10 BPS members.

AstraZeneca Prize for Women in PharmacologyA new prize, recognizing women whose career achievementshavecontributedsignificantlytoourunderstandingofaparticularfieldthroughexcellencein research was made available by a generous donation from AstraZeneca. The prize will be awarded annually, andwaspresentedforthefirsttimetoProfessorJuliaBuckingham (Imperial College London) at the Winter Meeting 2009. Professor Buckingham gave a short talk entitled ‘Stress, laughter and a following wind’. Future winners will be invited to present a lecture at one of ourscientificmeetings.

Women in Pharmacology (WiP) Mentoring SchemeThe mentoring scheme entered its third year of

operation and successfully paired 10 mentors and mentees during 2009.

Support for pharmacology training

Integrative Pharmacology Fund (IPF) This fund was established in 2004 to support high-quality in vivo training in integrative pharmacology, physiology, and toxicology research in UK universities. The IPF supported the following in vivo training initiatives during 2009:

Continued to support eight Academic Fellows at the University of Manchester (2), Kings College London (2), the University of Bristol (2), the University of Oxford (1), and the University of Surrey (1), and for three PhD students.

Provided additional funds to support Medical Research Council (MRC) in vivo PhD project costs at Liverpool, Oxford, Imperial, Glasgow, and Bristol (a total of 17 PhD projects).

Continued to contribute to and monitor the Integrative Mammalian Biology awards made to Imperial College, King’s College London, a consortium of Manchester and Liverpool universities, and a consortium of Glasgow and Strathclyde universities, with the MRC, Biotechnology and Biological Sciences Research Council (BBSRC), Higher Education Funding Council for England (HEFCE), Scottish Funding Council (SFC), and the Department of Trade and Industry (DTI).

Developed a new Research Council funded award scheme (Strategic Skills Awards) to support the costs of in vivo studentships with the MRC and BBSRC; the scheme will be launched in 2010.

In vivo teaching group — funded by the IPF and donations from industry The universities of Bath, Bristol, Glasgow, Leeds, Oxford, and Manchester were awarded funding to

support the in vivo training element of their courses during the 2008/2009 academic year. The agreed awards totalled around £32,000, which supported 110 pharmacology undergraduates.

Fourgrantsof£400eachwereawardedtofinal-yearpharmacology undergraduate students undertaking an in vivo project to cover the costs of obtaining a Home OfficeLicence.

BPS/Physiological Society In vivo short coursesThe in vivo short courses are held annually at King’s College London, the University of Glasgow, and Bristol University. Nine students attended the courses at each institution during 2009.

BPS Prescribing Initiative FellowDr Sarah Ross (University of Aberdeen) continued her work as BPS Prescribing Initiative Fellow. Sarah’s paper detailing a consultation undertaken during 2009, ‘Development of Learning Outcomes for an Undergraduate Prescribing Curriculum (British Pharmacological Society Prescribing Initiative)’, is due for publication in the British Journal of Clinical Pharmacology (Accepted Article Online: Nov 5 2009 DOI: 10.1111/j.1365-2125.2009.03581.x). The BPS Core Curriculum in Clinical Pharmacology and Safe Prescribing for Medical Students will be updated to reflecttheselearningoutcomesandthepublicationof Tomorrow’s Doctors 2009 by the General Medical Council (GMC).

Finally, a potential model for assessment of prescribing competence has been designed and options for piloting this are being explored.

Developing an understanding of pharmacology

Annual Meeting of the Association for Science Education (ASE) 2009 Reading, 6-9 January The BPS contributed to the ‘Biology in the Real


World: Bringing the Curriculum to Life’ symposium at the (ASE) 2009 Conference. Dr Emma Robinson (University of Bristol) delivered a talk about ‘Drugs of Abuse; Psychoactive and Performance Enhancing Drugs’ on behalf of the BPS and the Society for Endocrinology. We exhibited alongside other Society of Biology member organizations, and prepared the resource booklet ‘Biology in the Real World: Bringing the Curriculum to Life’, which was distributed at the symposium.

Cambridge Careers Fair, Cambridge, 4 March 2009The careers fair for medical students was well attended, and leading doctors and academics were on hand to show the advantages of the many and varied specialties. The Clinical Pharmacology stand was represented by the university of Cambridge pharmacology department and the BPS.

UCAS Careers Fair, London, 2 April, and Newcastle, 30 AprilThe BPS exhibited and provided student member representatives to these events for school leavers.

British Science Festival – Discover Biology, Guildford, 9 SeptemberThe Biosciences Federation and member organizations prepared a programme entitled ‘Discover Biology’. BPS members Professor Phil Routledge (University of Wales College of Cardiff) and Dr James McLay (University of Aberdeen) contributed to ‘Health supplements: The good, the bad, and the phony’ in partnership with speakers from the British Nutrition Society.

The Source Event, Career advice for Science Jobseekers, London, 25 September The BPS exhibited at this event, organized by Nature Jobs, in partnership with the Biochemical Society,

Physiological Society, Society for Endocrinology, and Society for Experimental Biology, at the Biosciences Federation/Institute of Biology stand.

IGC Annual Careers Guidance Conference and Exhibition 2009, Blackpool, 5 November The BPS exhibited at this careers event.

Life Sciences Careers Conference, King’s College London, 25 November The BPS, along with other member organizations of the newly formed Society of Biology, organized the conferenceandexhibition,targetedspecificallyatundergraduates and postgraduates.

The day included a programme of speakers from variousscientificsectors,whoprovidedcareersinformation, and career and cv workshops.

Resources

Biology in the Real World: Design for Lifehttp://www.bps.ac.uk/uploadedfiles/schools/BPSResourceBooklet.pdf

Prescribehttp://www.prescribe.ac.uk/

Practical Biology http://www.practicalbiology.org/

Jenni Cryan

Diploma Graduates 2009

Sara Pritchard


‘Currying favour’ at the Science of Curry event, Cheltenham Science Festival 2009


External affairs We continued to extend outreach and engagement activities with both the national and international media and the public:

Festivals

Building on a number of successful science festival appearances in the previous year, the BPS engaged in two major events to increase awareness of pharmacology among the public.

Professor Clive Page led an interdisciplinary team of scientists to the Cheltenham Science Festival in June to present ‘The Science of Curry’. The presentation, which was introduced by BPS President Dr Jeff Aronson and featured chemist Dr Andrea Sella and engineer Dr Mark Miodownik, curried favour among the packed audience with a mouth-watering fusion of science and spice. Topics covered over the course of the evening included the surprising healthbenefitsofcurryseasoning,fromslowingtheonset of Alzheimer’s disease to protecting against cancer and arthritis. With demonstrations and tasty samples on offer, the presenters explained the subtle chemistry of perfectly blended spices and the delicate engineering of a crunchy poppadum.

In September, a session on Dietary Supplements at the British Science Festival, was organized jointly with the Biochemical Society and the Nutritional Society and was presented by Dr James MacLay and Professor Phil Routledge. The session, titled ‘Supplements: the good, the bad and the phony’ was over-subscribed and resulted in press reports highlighting Dr MacLay’s concerns that people may be unaware of the potential for homoeopathic remedies to undermine conventional medicines. These reports were further trailed on our website.

Consultations

February 2009• ScienceCouncilScienceinHealthproject

• Reviewofprescriptionofantipsychoticdrugsfor people with dementia

March 2009• JointSpecialtyCommitteefunctionfeedback

• RCPhealthrecordstandardsworkshop

June 2009• EU86—jointbiosciencesectorresponseto HomeOfficeconsultation

August 2009• QCAConsultationonGCSEScienceCriteria: BPS responded via BSF

September 2009• Settingscienceandtechnologyresearchfunding priorities: BPS responded via IoB

• ScienceandLearning.AresponsetotheDCSF/BIS Science and Learning Expert Group: BPS response via IoB

December 2009• ProposalsfortheResearchExcellence Framework (REF)

In addition to the consultations above, the BPS responded to several Medicines and Healthcare products Regulatory Agency (MHRA), and European Medicines Agency (EMEA) calls for input.

Media

In addition to public outreach work, we engaged in an increasing amount of articles and features in the national and international media.

Our press agency, Stehm Media, issued several press releases and monitored related media activity. During the Summer Meeting in Edinburgh, articles on the positiveimpactofflavonoidsonAlzheimer’sdiseasewere published in both the Scotsman and Daily Express newspapers. Further success was achieved from evidence linking coughing with irritation of TRPA1 receptors. This story was picked up in the Scotsman newspaper and on the BBC news website.

Media activity increased again during our Winter Meeting.Apressbriefing,whichcoveredarangeof issues around safe prescribing, was led by BPS President Dr Jeff Aronson and Professor Simon Maxwell, Chair of our Prescribing Committee. This resulted in a wealth of media interest in the national and international press, and online, with articles featured in: The Times, Financial Times, Daily Mirror, Telegraph, Press Association, and Onmedica.Thebriefingalsoreachedanumberof publications targeted at new but important audiences for the BPS: the Nursing Times, Pharmacy Europe, Prescriber, Pjonline, and e-Health Insider.

Our media strategy developed during this period, with a more proactive approach to press interaction being taken. Closer links between the BPS and the Science Media Centre led to increased contact between journalists looking for expert opinion and comment. In addition, more of our members have offered their services to deal


with press enquiries as and when they arise.

As a result our media impact grew exponentially, with appearances from our members on television (Sky News – the link between Michael Jackson’s death and inappropriate use of propofol), and radio (BBC Radio 4, Woman’s Hour – Prescribing antidepressants during pregnancy; BBC Radio 5 Live and Radio 1 – Laxative abuse among anorexic teenagers). BPS members also contributed to a diverse range of stories, from the future of personalized medicines to the increased numbersoffilmandmusicstarsfallingvictimtothe adverse effects of prescription drugs in the US. All BPS press appearances are listed on this page.

Website redevelopment

In the autumn, work began on redeveloping the BPS website. Wiley Blackwell, which holds the publishing contract for our journals, was chosen as our supplier, and a round of consultations among BPS committeeswasundertakentofindoutwhatourmemberswouldfindusefulinthenewsite.Thesiteis expected to go live over the summer of 2010.

Social networking

In addition to this redevelopment, we began to engage in some key social networking activities. Our Twitter feed, which is used to communicate pharmacological news stories and items of interest, extended its user group by around 200 percent. The BPS also launched its own Facebook page, and attracted around 300 users within four months. It is hoped that these new channels of communication will broaden our impact on the web, engage the public in consideration and debate, and present the BPS as a place to visit for information, discussion, and advice on all things pharmacological in 2010.

Science policy

TheBPShascontinuedfinancialsupporttoanumber of organizations, including the Biosciences Federation, which has now merged with the Institute of Biology to form the Society of Biology. It is hoped that this merger will create a more unifiedvoiceforbiology,particularlyinadvisingGovernmentandinfluencingpolicy,aswellasadvancing education and professional development.

Resources

Twitterhttp://twitter.com/BritPharmSoc

Facebookhttp://www.facebook.com/pages/British-Pharmacological-Society/99860469636?ref=ts

Society of Biologyhttp://www.societyofbiology.org/home

Pharmacology in the Newshttp://www.bps.ac.uk/site/cms/contentCategoryView.asp?category=446

BPS in the news

7 JanuaryBJP press release: Angina New Drug Gets Right to the Heart of the Problem

22 JanuaryProfessor Webb addresses the Commons Health Select Committee on prescribing. Press coverage: BBC News Online, Today Programme, BBC Radio Wales Financial Times: Doctors Alerted over Drugs Training The Telegraph: Patients ‘at Risk because Doctors not Trained to Prescribe Drugs Properly’ Daily Mail: Young Doctors ‘Putting Lives at Risk’ through Lack of Training in Prescribing Drugs

11 AprilThe UK’S NHS and pharma: need for more clinical pharmacologists. BPS response published in The Lancet

11 JuneBJP press release: Muscular dystrophy: new drug promisesbenefitwithoutriskofinfections

8-10 July BPS Summer meeting press releases: Chemicals found in fruit and veg offer dementia hope Press coverage: Daily Express, The Scotsman, Evening News Study may cough up new treatment for a tickly throat Press coverage: BBC News Online, The Scotsman

5 AugustBJP press release: Neuropathic Pain: The Sea Provides a New Hope of Relief Press coverage: BBC News Online

3 SeptemberBJCP press release: Rise in Weight-Loss Drugs Prescribed to Combat Childhood Obesity Press coverage: BBC News Online, Metro, Independent


8 September In search of the right remedy Dr Jeff Aronson contributed to the growing debate on teaching medical students about practical prescribing. Press coverage: The Times

10 September Supplements – the good, the bad, and the phony Dr James McLay, represented BPS at the British Science Festival supplements debate. Press coverage: Daily Mail

12 OctoberBack to the future in personalized medicine Professor Donald Singer contributed to a Reuters article on genetic clues in old and new medicines.

14 October BJCP press release: Don’t Block Folic Acid in Early Pregnancy: Medications that Block Folic Acid are Associated with Increased Abnormalities.

19 October Can drugs for Parkinson’s disease cause uncontrollable desires? BPS member Peter Jenner, Professor of Pharmacology at King’s College London, commented on the adverse effects of drugs used to treat Parkinson’s disease. Press Coverage: The Telegraph

29 October BJP press release: New Hope for Sufferers of Overactive Bladder.

2 DecemberPrince Charles: ‘Herbal medicine must be regulated’. Professor David Colquhoun comments

3 December BPS press release: BPS expresses dismay at sidelining of education in GMC report on prescribing errors.

4 DecemberEating disorder charity wants better control over sales of laxatives BPS supported call for better supervision of over-the-

counter medicines. Press coverage: BBC News Online

11 December BMJcriticismsofTamifluquestioned Professor Donald Singer contributes to the New ScientistonBMJcriticismsofTamiflu. 14 December A blueprint for safer prescribing: BPS expresses concern about poor prescribing and calls for greater collaboration in solving the problem. Press Coverage: The Times, Financial Times, Daily Mirror, The Telegraph, Virgin Media, Nursing Times, Pharmacy Europe, PJonline, e-Health Insider 15-17 December Winter meeting press releases: ‘Sat nav’ jamming could help tackle disease funding says researcher Press coverage: Science Daily

Industry-academia must work together in order to win ‘increasingly scarce’ resources

Cannabishopeforinflammatoryboweldisease Press coverage: The Telegraph, Science Ticker, Ansa, Current

Meet at Angel Gate

The refurbished conference room at our London headofficeisnowavailableformembersand non-members to book for meetings, workshops, teleconferences and lectures.

The facilities can accommodate up to 24 boardroom style, or up to 35 delegates theatre style.

BPS members are also welcome to make use of the new hot-desk area in our library.

For enquiries, please email: [email protected]

Conference room

Hot desk area


ISSN No: 1757-8175

The Newsletter of the British Pharmacological SocietyVolume 2 Issue 2, June 2009

Clinical Special IssueIn this Issue:

Pg 5. Message from the EACPT President, David Webb

Pg 6. NICE at Ten

Pg 7. Prescribe e-Learning for Clinical Pharmacology and Prescribing

Pg 8. Non-Medical Prescribing Where are we now?

Pg 10. BJCP Young InvestigatorPrize Award Winner - Celestino Obua

Pg 12. The BPS AdvancedPharmacology Diploma and the Clinician: A Training Opportunity

Pg 12. Update on the Faculty of Pharmaceutical Medicine (FPM) Diploma and Certificate in Human Pharmacology

Pg 13. BPS Prescribing Initiative

Pg 14. Writing Pharmacological History

Pg 18. Book Review: Bad Science

Congress of the European Association for Clinical Pharmacology and Therapeutics Edinburgh, Scotland 12-15th July 2009

ISSN No: 1757-8175

The Newsletter of the British Pharmacological Society

Volume 2 Issue 3, December 2009

Celebrating Charles Darwin

In this Issue:

Pg 4. A Great Instauration

Pg 9. Historical Perspectives:

Rosalind Franklin

Pg 10. Introducing Genomics

and its Offspring

Pg 11. Pharmacology in the

Post Genomic Era

Pg 13. Personalised Medicines

Pg 15. The Future of Clinical

Pharmacology

Pg 17. Harnessing the Power

of Molecular Biology

in Pharmacology

Pg 20. Clinical Pharmacology

and Primary Care

Pg 22. CPT or Huliatrics?

Pg 24. A Model for Academic

Clinicians

Since January 2009 both journals have been published by Wiley-Blackwell. This move has created an opportunity for the journals to expand their respective coverage to encapsulate the whole spectrum of pharmacology


PublicationsThe Society publishes two Pharmacology Journals; the British Journal of Pharmacology (BJP), published bi- monthly; and the British Journal of Clinical Pharmacology (BJCP), published monthly:

Since January 2009 both journals have been published byWiley-Blackwell.Thejournaleditorialofficeswerecentralized in April and are now managed by a Wiley-Blackwell editorial team based in Oxford.

Professor Ian McGrath (University of Glasgow) began his tenure as Editor-in-Chief of BJP and Professor Jim Ritter began his second year as BJCP Editor-in-Chief.

BJPimplementedfreecolourfiguresforthefirsttimefrom January 2009, and in early 2010 the front covers will be aligned, a visual indicator that our journals are working together to cover all of pharmacology.

Special on-line issues called virtual themed issues (VTI) were started as a means of highlighting areas of strength of the journals. One of these, on ‘Endothelium’, included articles from both BJP and BJCP. Combining articles from both journals in virtual issues is an initiative that the journals will look to repeat during 2010.

VTI’swerealsousedtopromotespecificareasatspecialist meetings.

British Journal of Pharmacology

During 2009 BJP:Received 1533 articles

Published 475 articles

Published 74 Review Articles

2008ImpactFactorof4.902,anincreaseof30%

Published six themed issue/sections

31 Editors and 4 Reviews Editors joined the board

One Editor and one Reviews Editor retired

BJP published the following themed issue/sections: Endothelium in Pharmacology, Volume 157(4); June 2009

Histamine Pharmacology, Volume 157(1); May 2009

Vector Design and Drug Delivery: On the Road to Gene Therapy, Volume 157(2); May 2009

GPCR, Volume 158, Issue 1 (Sep 2009)

MediatorsandReceptorsinResolutionofInflammation,Volume 158(4); Oct 2009

Guide to Receptors and Channels (GRAC) 4th Edition

During 2009 GRAC:Published a hard copy, Volume 158(1); Nov 2009

Agreed not to publish an online version; the next hard copy update will be in 2011

Securedfundinguntil2011;Pfizerhasagreedtocontinue as lead sponsor

British Journal of Clinical Pharmacology

During 2009 BJCP:Received 527 articles

Published 236 articles

Published 7 Review Articles

Hada2008ImpactFactorof3.128,anincreaseof17%

Published a monthly ‘editors’ view’

Initiated a series on the mechanisms of truly novel recently licensed drugs

Published abstracts of the Dutch and of the German clinical pharmacology society meetings

4 Editors, 5 Executive Editors and 4 Reviews Editors joined the board

5 Editors and 5 Exec Editors retired

BJCP published the following themed issue/sections:Medication errors special issue. Volume 67(6); June 2009

Obesity themed section. Volume 68(6); Dec 2009

BJCP published the following Abstracts:2009 Annual Meeting of the German Clinical Pharmacologists, 21–24 October 2009, Heidelberg, Germany. Volume 68(1); Oct 2009

Proceedings of the British Pharmacological Society Clinical Pharmacology section 16–18 December 2008 Hilton Metropole Hotel. Volume 68(2); Aug 2009

Pharmacology Matters

Three themed issues of the BPS magazine were published during 2009, complemented by 12 e-bulletins.

Nutrition, Volume 2(1);Apr 2009Commissioned to complement the Advances in Nutritional Pharmacology themed section published in BJP, the articles focused on the value of dietary components to cardiovascular health.

Clinical, Volume 2(2); June 2009 Published to coincide with NICE’s 10th anniversary and the EACPT 2009 meeting in Edinburgh, a copy of this issue was distributed to all delegates at the EACPT


Congress in Edinburgh and to Heads of Pharmacy departments in the UK. We shall continue to send future issues to these pharmacy contacts.

Charles Darwin at 200, Volume 2(3); Dec 2009 Celebrating Charles Darwin and his contribution to pharmacology, this issue covered the discovery of the of structure DNA, the Human Genome Project, theemergingfieldofgenomics,thepromiseofpersonalized medicines, and the embracing of genetic techniques by pharmacologists in their everyday thinking and research.

Resources

British Journal of Pharmacologyhttp://www.brjpharmacol.org

British Journal of Clinical Pharmacologyhttp://www.bjcp-journal.com/

GRAChttp://www3.interscience.wiley.com/journal/122684220/issue?

Pharmacology Mattershttp://www.bps.ac.uk/site/cms/contentCategoryView.asp?category=376

BJCP


Structure, governance and managementThe Society’s governing document is its Memorandum, Articles of Association, and Rules. In 1994, the Society became a Company Limited by Guarantee and therefore has no share capital. In the event of its winding up, the members’ liability is limited to £1 each.

The Trustees are legally responsible for the overall governance, strategy, and direction of the Society. In terms of the Charities Act 2006, Trustees are accountable to the Charity Commission for ensuring that the Society’s objectives as a registered charity are being met. The Trustees are also the Directors of the British Pharmacological Society. The Council of Trustees, which meets twice a year, comprises the President (Chair), President-elect, Honorary Treasurer, Chairman of the Committee of Heads of Pharmacology,

Chairman of the Heads and Professors of Clinical Pharmacology and Therapeutics, and four elected members (of whom at least one is from industry and one from the clinical section at the time of election). A full list of the trustees can be found on page 29.

Elections to the Council take place each year at the AGM, and any paid up member of the Society, ordinarily resident in the UK, can stand. Trustees are elected to serve for periods of between three and four years,dependingonoffice.

Trustee Induction and TrainingA job description has been produced for Council members,whichspecifiestheknowledge,skills,andattributes that are needed by the members. Trustee training is undertaken at regular intervals.

Executive CommitteeCouncil has delegated responsibility to the Executive Committee to oversee the day to day operations of the Society. Members of the Executive Committee are theelectedofficersoftheBPS,togetherwithtwomembers directly elected by the membership. The usualtermofofficeforExecutiveCommitteemembersis three years.

Committees and Working GroupsThe Council (and Executive Committee) also have Committees and Working Groups, to whom powers are delegated. The Committees and Groups report back to Council directly or via the Executive Committee, depending on their constitution. Members of these Committees and Groups comprise both Council and/or Executive Committee appointments, together with other members. The Clinical Pharmacology Section Committee (which is a sub-committee of Council) manages the affairs of the Clinical Pharmacology Section. The Journals are managed by the Executive Management Committees of their Editorial Boards.

How the Society is OrganizedThe Council has ultimate responsibility for the Society’s management, with the exception of those matters that must be decided by a general meeting of the members. The Council focuses on strategy and the Executive Committee is delegated the responsibility for the general management of the Society’s activities. The Trustees employ a Chief Executive, who is responsible for executing the decisions of committees and sub-committees and for the day to day management of the Society’s resources, including the

other employees and the Angel Gate building. At 31 December 2009 we had 10 full time staff and utilized the services of specialist consultants as required. The current staff and their respective job titles can be found on page 30. The Chief Executive reports back to Council and Executive Committee on performance against the objectives of the BPS.

TheSocietybenefitsfromagreatdealofvoluntarywork by its members in the organization of meetings, editing, and refereeing of manuscripts, service on committees and panels, and many other activities.

The Society participates actively in the wider biosciences community, both in the UK and internationally, through a variety of activities, including collaborative funding of research and educationinitiativesandthehostingofscientificmeetings.

Risk AssessmentThe Trustees regularly review the risks to which the Society is exposed, particularly activity, operational, andfinancialrisks,andensurethatproceduresandreportingregimestomanageandreduceanyidentifiedrisks are in place.

The prime risk to which the Society is exposed continuestobefinancial,particularlyinrespectoftheincome from our journals. This risk is the predominant determinate of the level of free reserves held by the Society pursuant to its Reserves Policy.


Donors during 2009We are most grateful to the following organizations for donations to support the various activities during 2009, including meetings, journals, prizes and training courses:AstraZeneca,Pfizer,GlaxoSmithKline,MSD,Wiley-Blackwell Publishing, Novartis, Huntingdon Life Sciences, Trends in Pharmacological Sciences, Aptuit, MEDA Pharmaceuticals, Tocris Bioscience, Matrix Biologicals Ltd. MedImmune, Wyeth Research, B&K Universal Ltd, Millipore, Royal Microscopial Society, Department for Business Innovation and Skills, Scottish Funding Council, Higher Education Funding Council for England, Medical Research Council, BBSRC, DiscoveRx, Perkin Elmer and the Technology Strategy Board.

Professional AdvisersBankers: Cooperative Bank plcSolicitors: Messrs. Boyes TurnerAccountancy Adviser: David O Douglas (Chartered Accountant) Auditors: French Duncan LLP (Chartered Accountants & Registered Auditors) VAT Consultants: Haslers (Chartered Accountants)Investment Managers: Brewin Dolphin

2009 BPS council members: Martin Todd, Peter Roberts, Phil Routledge, Jeff Aronson, Ray Hill, Danny McQueen and Kim Dora


Trustees and Executive Committee

Dr Robin Hiley

Vice-President Meetings

Professor David Williams

Vice-President Clinical

Dr Anthony Davenport

Vice-President External Affairs

Professor Susan Brain

Vice-President Academic

Development

Professor Robin Plevin

Elected Member (Younger Members)

Professor Cherry Wainwright

Elected Member (Pharmacology

Matters)

Professor Ian McGrath

Editor-in-Chief BJP

Professor James Ritter

Editor-in-Chief BJCP

Dr Peter Jackson Chairman of the Clinical

Section

Dr Jeff Aronson

BPS President

Professor Ray Hill

President- Elect

Professor Daniel McQueenHonorary Treasurer

Professor Peter RobertsChair of

Committee of Heads of

Pharmacology

Professor Gordon McInnes Chair of Clinical

Committee of Heads of

Pharmacology

Officer trustees

Executive Committee

Elected trustees

Dr Gillian EdwardsElected Trustee

Dr Kim Dora Elected Trustee

Professor Phil Routledge

Elected Trustee (Clinical)

Dr Martin Todd Elected Trustee

(Industry)

Professor Kevin Park Co-opted Member


BPS Staff

Kate Baillie

Chief Executive

E-mail: [email protected]

Hazel O’Mullan

Publications Manager


Paul Tizard

MembershipandOfficeAdministrator


Kevin Kearns

Deputy Chief Executive


Carol Medal

Information Systems Manager


Sue Giles

Accounts Administrator


Jonathan Brüün

Head of Communications and Development


Amalie Brown

Meetings Manager


Karen Schlaegel

Secretariat Services Manager



Financial reviewUnrestricted Funds - Result for the year The Society’s “unrestricted” charitable activities (excluding investment transactions) for the year to 31 December 2009 resulted in a surplus of £283.9k (see “NET INCOMING/(OUTGOING) RERSOURCES FOR THE YEAR” in the Statement of Financial Activities), comparedwithadeficiencyof£125kfortheprevious9monthperiodto31December2008.Theresultreflectsthe very positive performance from our publishing activities, (inclusive of a reduction in related direct staff costs following a decision to outsource certaineditorialofficeactivities).Thesegainswereoffset to some extent, by one off costs related to a refurbishmentoftheAngelGateoffices.

Income & ExpenditureThe charts show the income and expenditure attribution for the period. Overall, the Society spent £2,698.5k (period to 31 December 2008: 2,668.2k) on itscoreactivities,alittleover90%oftotalincomingresources. In addition, a transfer of £5.0k was made to Restricted Funds in respect of a donation to the In-Vivo Teaching initiative.

PublicationsThe British Journal of Pharmacology and the British Journal of Clinical Pharmacology continue to provide the substantive portion of the Society’s unrestricted funds. The net income for the period under review (£1,405.5k) compares favourably with that for the 9 month period to 31 December 2008 (£607.3k). 2009wasthefirstyearinwhichbothjournalswerepublishedbythesamepublisherandthefinancialresultreflectstheeconomiesachievedfrom

outsourcing certain editorial activities, favourable exchange rate movements and reprint sales in respect of British Journal of Clinical Pharmacology articles.

ScientificMeetingsOur 2009 programme included focused, James Black and our annual summer and winter meetings held in Edinburgh and London respectively. In excess of 1,700 delegates attended these meetings.

Society Members continue to enjoy free access to the Society’s main meetings and thus revenue derives mainly from non-member registration fees and fees for focused meetings, trade exhibitions and sponsorship. PromulgatingexcellentscientificresearchbyrunninghighqualityscientificmeetingsisoneoftheSociety’sprime objectives. Providing access to such meetings at zero or subsidised cost continues to be a key element oftheSociety’sfinancialstrategy.

Educational ActivitiesUnrestricted expenditure on educational activities during the period totaled £384.4k (period to 31 December 2008: £222.3k) including grants totaling £198.2k to universities, students and other bodies and £24.8k of prizes to science and medical undergraduates.

Members’ ServicesIncome from membership subscriptions continues toreflecttherelativelystableconstituentsofourmembership portfolio. Total expenditure on services for members in the period under review was £416.4k (period to 31 December 2008: £246.1k). The relative increase in overheads results from the refurbishment, reorganization and restructure of the Angel Gate officeandthegreateremphasisoncommunicationanddevelopment activities. Production and distribution

Following changes in the Companies Act rules the Trustees decided in 2008, to bring the Society’s accounting period into line with its core revenues which derive from its publishing activities. Accordingly, this review compares the finances for the 12 months to 31 December 2009, with the 9 month period to 31 December 2008:


costs for Pharmacology Matters, the Society’s in-house journal, continue to decrease whilst subscriptions to other organizations remain at approximately the same level to those which would have been paid in a 12 month period to 31 December 2008.

Other CostsCentralOfficeoverheadsnotdirectlyattributableto other activities and Governance Costs were in line with expected levels for the increased reporting period under review and there were no extraordinary expenditure items.

Investment PerformanceThe period to 31 December 2009 was also a positive period for our investments which posted net gains of £590.1k compared to net losses of £702.3k in the 9 months to 31 December 2008, primarily due to the upturn in global markets since March 2009. The investments are benchmarked against the APCIMS (Association of Private Client Investment Managers and Stockbrokers) Balanced and Growth benchmarks. In the period under review, these roseby16.6%and19.8%respectively,whilsttheFTSE100IndexofLeadingSharesroseby27.3%.

Restricted FundsOur restricted fund balances remain wholly adequate to support current levels of commitments and liabilities. The largest tranche of restricted funds supports the Integrative Pharmacology Fund which in turn supports research and training in integrative pharmacology. Major donations during the period resulted from industry support for the Society’s in-vivo educational activities (£102.5k); an MRC grant (£76.8k) to run a short course in translational pharmacology and £50k from the Department of Health to facilitate payments to authors and reviewers for contributions to e-learning for health modules being developed between the Society and Department for Health for the 38,000 medical students who train each year in the UK.

Balance SheetAfter accounting for the movements detailed above, the balance sheet continues to evidence thattheSocietyhasthefinancialresourcesrequired to meet its charitable objects.

Reserves PolicyThe Trustees have adopted a Reserves Policy which they consider appropriate to the Society’s medium and long-term charitable objects. Following a Risk Assessment review in 2009, the Society has revised the level of free reserves held to ensure that the Society is able to meet its charitable objects and otherfinancialcommitmentsfrom4to2years’working capital (excluding publishing activities).

Investment PolicyThe Society’s investments are managed on a fully discretionary basis by Brewin Dolphin Securities.

The current investment strategy is designed to underpin the Society’s free reserves requirement, providing a buffer against sudden loss of income (pending a restructure to a revised, balanced budget) from its traditional activities. We also need to invest to meet medium/long-term liabilities which may arise from our usual activities, and to provide for major capital expenditure items.

In late 2009, the residual balance in Society’s 75th Anniversary Strategic Initiatives Fund (“ASIF”) was transferred to general funds, the ASIF having served its purpose.

PublicBenefitsTestTheTrusteesconfirmthattheyhavecompliedwiththeduty in Section 4 of the Charities Act 2006 to have due regard to the Charity Commission’s general guidance onpublicbenefit“CharitiesandPublicBenefit”.

The Society is the primary UK learned society concerned with research into drugs and the way they work. The Society’s activities support the education of scientists, clinicians, school students

and the general public and the dissemination of research in pharmacology and clinical pharmacology. Pharmacology is responsible for the discovery of hundreds of chemicals used in the treatment of disease and the relief of human and animal suffering, as well as contributing substantially to the success of the pharmaceutical and healthcare industries.

HONORARY TREASURER’S STATEMENTTheSociety’smediumtermfinancialstrategyistowork within a budget which is determined by our contracted income. Budgets for charitable activities are bid for by our various operational committees and agreed by the Trustees. Expenditure within budgets is delegated to the committees who must account for both spend and value for money in subsequent budget rounds, and this regulated devolved budgetary process is now established and working very well. An overviewoftheSociety’sfinances,includingdetailedmanagementreportsandcashflowsummaries,isprovided to the Trustees at regular intervals during the year, and the Finance Committee reports to theTrusteesandExecutiveCommitteeonfinancialprudence,costcontrolandmaximizingefficiency.

IamverypleasedtoreporttheSociety’sfinancesremain wholly adequate for achieving the society’s charitable objectives and our general funds (reserves) have continued to recover most of the value lost in 2008asaresultofthefallinworldfinancialmarkets.Thanks to the outperformance from publishing activities, our charitable expenditure amounted to a littleover90%ofincomingresourcesandtheexcessrevenue will be used to underpin a series of projects in 2010 aimed at improving our ability to communicate with members and the wider community, and to further develop the Society’s services to industry, healthcare and education.

The net result for the period also includes expenditure to rearrange the Angel Gate premises following transferoftheEditorialOfficetoWileyBlackwell;thishas resulted in greater productivity and reduced costs as all committee meetings are now held at Angel Gate.


In addition, a library and “hot desk” area for members has been made available.

The Society continues to deliver quality and value for money services in furtherance of its charitable objects, brought about by the hard teamwork of volunteers and the staff at Angel Gate. The improvements in our communication and development tools to come online in 2010 and initiatives in respect of industry liaison and clinical pharmacology will ensurethattheSocietycontinuestoleadthefieldinservices for pharmacologists and the wider community.

SUMMARY FINANCIAL STATEMENT

ThefinancialinformationsetoutinthisSummaryFinancial Statement is only a summary of information derived from the charity’s annual accounts. It does not contain additional information derived from the trustees’annualreport.Itdoesnotcontainsufficientinformation to allow as full an understanding of the results and state of affairs of the charity as would be provided by the full annual accounts and report.

Members requiring more detailed information can obtain a full copy of the charity’s annual accounts andtrustees’annualreportfromtheSocietyOfficeorfrom the Member Information section of the Society’s website. Members who wish to elect to receive a full copyoftheannualaccountsforallfuturefinancialyearsshouldcontacttheSocietyOffice.

Statement of the Independent Auditor to the Members of the British Pharmacological SocietyWehaveexaminedthesummaryfinancialstatementfor the year ended 31 December 2009.

Respective responsibilities of the trustees and the auditorThe trustees (who also act as directors of the charity for the purposes of company law) are responsible forpreparingthesummaryfinancialstatementinaccordance with applicable United Kingdom law.

Our responsibility is to report to you our opinion on theconsistencyofthesummaryfinancialstatement

withthefullannualfinancialstatements,anditscompliance with the relevant requirements of section 427 of the Companies Act 2006 and the regulations made thereunder.

We conducted our work in accordance with Bulletin 2008/3 issued by the Auditing Practicies Board. Ourreportonthecompany’sfullannualfinancialstatements describes the basis of our opinion on those financialstatements.

OpinionInouropinionthesummaryfinancialstatementisconsistent with the full annual accounts of British Pharmacological Society for the year ended 31 December 2009 and complies with the applicable requirements of section 427 of the Companies Act 2006, and the regulations made thereunder.

FRENCH DUNCAN LLPChartered Accountants and Registered Auditors

56 Palmerston Place Edinburgh EH12 5AY

Date

STATEMENT OF TRUSTEESTheauditorhasissuedunqualifiedreportsonthefull annual accounts and on the consistency of the trustees’ annual report with those annual accounts. Their report on the full annual accounts contained no statement under sections 498(2) or 498(3) of the Companies Act 2006.

Signed on behalf of the trustees by:

DANIEL S MCQUEEN Honorary Treasurer


Statement of financial activities (incorporating the income and expenditure account) Year ended 31 December 2009STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME AND EXPENDITURE ACCOUNT)

YEAR ENDED 31 DECEMBER 2009

INCOMING RESOURCES

Unrestricted Funds

Restricted Funds

Total Funds Year to

31 Dec 09

Total Funds Period from 1 Apr 08 to 31 Dec 08

Incoming Resources from generating funds:

Voluntary Income 256,280 256,280 89,650 Investment Income 89,198 59,746 148,944 226,901

Incoming Resources from Charitable Activities

2,857,390

2,857,390

2,371,918 Other Incoming Resources

40,838

-

40,838

60,967 TOTAL INCOMING RESOURCES 2,987,426 316,026 3,303,452 2,749,436

RESOURCES EXPENDED Costs of generating funds:

Investment management costs

(18,921)

(18,921)

(13,683)

Charitable Activities (2,640,061) (39,479) (2,679,540) (2,831,613) Governance Costs (22,903) (22,903) (17,452) Other Resources Expended (16,609) (16,609) TOTAL RESOURCES EXPENDED (2,698,494) (39,479) (2,737,973) (2,862,748)

NET INCOMING/(OUTGOING) RESOURCES BEFORE TRANSFERS

288,932

276,547

565,479

(113,312)

Transfer between funds (5,000) 5,000

NET INCOMING/(OUTGOING) RESOURCES FOR THE YEAR

283,932

281,547

565,479

(113,312)

Realised Gains/(Losses) on disposal of investment assets

26,142

26,142

(63,463)

NET INCOME/(EXPENDITURE) FOR THE YEAR

310,074

281,547

591,621

(176,775)

OTHER RECOGNISED GAINS AND LOSSES

Loss on revaluation of fixed assets for charity’s own use

(30,000)

(30,000)

Gains/(Losses) on revaluation of investment assets

590,070

590,070

(702,318)

NET MOVEMENT IN FUNDS

870,144

281,547

1,151,691

(879,093)

Carried Forward

870,144

281,547

1,151,691

(879,093)

Unrestricted Funds

Restricted Funds

Total Funds Year to

31 Dec 09


Brought Forward

870,144

281,547

1,151,691

(879,093)

RECONCILIATION OF FUNDS

Total Funds brought forward

3,336,419

1,096,718

4,433,137

5,312,229

TOTAL FUNDS CARRIED FORWARD

4,206,563

1,378,265

5,584,828

4,433,136

The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of total recognised gains and losses has not been prepared. All of the above amounts relate to continuing activities.

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING THE INCOME AND EXPENDITURE ACCOUNT) YEAR ENDED 31 DECEMBER 2009

INCOMING RESOURCES

Unrestricted Funds

Restricted Funds

Total Funds Year to

31 Dec 09


Incoming Resources from generating funds:

Voluntary Income 256,280 256,280 89,650 Investment Income 89,198 59,746 148,944 226,901

Incoming Resources from Charitable Activities

2,857,390

2,857,390

2,371,918 Other Incoming Resources

40,838

-

40,838

60,967 TOTAL INCOMING RESOURCES 2,987,426 316,026 3,303,452 2,749,436

RESOURCES EXPENDED Costs of generating funds:

Investment management costs

(18,921)

(18,921)

(13,683)

Charitable Activities (2,640,061) (39,479) (2,679,540) (2,831,613) Governance Costs (22,903) (22,903) (17,452) Other Resources Expended (16,609) (16,609) TOTAL RESOURCES EXPENDED (2,698,494) (39,479) (2,737,973) (2,862,748)

NET INCOMING/(OUTGOING) RESOURCES BEFORE TRANSFERS

288,932

276,547

565,479

(113,312)

Transfer between funds (5,000) 5,000

NET INCOMING/(OUTGOING) RESOURCES FOR THE YEAR

283,932

281,547

565,479

(113,312)

Realised Gains/(Losses) on disposal of investment assets

26,142

26,142

(63,463)

NET INCOME/(EXPENDITURE) FOR THE YEAR

310,074

281,547

591,621

(176,775)

OTHER RECOGNISED GAINS AND LOSSES

Loss on revaluation of fixed assets for charity’s own use

(30,000)

(30,000)

Gains/(Losses) on revaluation of investment assets

590,070

590,070

(702,318)

NET MOVEMENT IN FUNDS

870,144

281,547

1,151,691

(879,093)

Carried Forward

870,144

281,547

1,151,691

(879,093)

Unrestricted Funds

Restricted Funds

Total Funds Year to

31 Dec 09


Brought Forward

870,144

281,547

1,151,691

(879,093)

RECONCILIATION OF FUNDS

Total Funds brought forward

3,336,419

1,096,718

4,433,137

5,312,229

TOTAL FUNDS CARRIED FORWARD

4,206,563

1,378,265

5,584,828

4,433,136

The Statement of Financial Activities includes all gains and losses in the year and therefore a statement of total recognised gains and losses has not been prepared. All of the above amounts relate to continuing activities.

-

-

-

--

-

-

-

-

-

-


Balance sheet 31 December 2009

BALANCE SHEET 31 DECEMBER 2009

2009 2008 £ £ £ FIXED ASSETS Tangible Assets 662,203 685,164 Investments 2,740,462 2,268,199 3,402,665 2,953,363 CURRENT ASSETS Debtors 762,881 447,669 Investments 983,557 2,973,811 Cash at bank and in hand 2,199,041 1,097,173 3,945,479 4,518,653 CREDITORS: Amounts falling due within one year

(1,242,779)

(2,308,207)

NET CURRENT ASSETS 2,702,700 2,210,446

TOTAL ASSETS LESS CURRENT LIABILITIES

6,105,365

5,163,809

CREDITORS: Amounts falling due after one year

(520,537)

(730,673)

NET ASSETS 5,584,828 4,433,136

FUNDS Restricted Income Funds 1,378,264 1,096,717

UNRESTRICTED INCOME FUNDS: Unrestricted Income Funds 3,781,381 2,990,235 Revaluation Reserve 425,183 346,184 TOTAL UNRESTRICTED INCOME FUNDS

4,206,564

3,336,419

TOTAL FUNDS 5,584,828 4,433,136

These financial statements were approved and signed on behalf of the Trustees on 11 June 2010 by: D S McQueen Honorary Treasurer Company Registration Number: 2877400


Our objectives for 2010Throughouttheyear,ourOfficersandtheSecretariatwillworktogethertodeliverintegratedservicestomembersandexternalgroups,toensurethattheneedsofbasicscientists,cliniciansandindustrialistsaremetasefficientlyandeffectivelyaspossible,acrossthefollowingareas:

Education and meetings

• Promulgateexcellentscientificresearch byrunninghigh-qualityscientificmeetings and educational courses, including exploring collaboration with other Societies, in particular the Society of Biology. Develop more distinct identitiesforeachtypeofscientificmeeting, capitalizing on the success of the James Black concept.

• Continuetodevelopanddeliverhigh- quality Diploma workshops and e-learning resources; maintain a presence at undergraduate/ careers fairs and teachers’ conferences; use the enhanced BPS website to promote education, especially in Integrative Pharmacology.

• WorkwiththeDepartmentofHealth’se-Learning for Health Initiative to deliver Prescribe, a web-based training tool to inculcate safe prescribing principles in the training of undergraduate medical students. Work with the Medical Schools Council and other stakeholders to develop a national Prescribing Skills Assessment scheme.

• Continuetobuildonthesuccessofrecent efforts to promote the renaissance of clinical pharmacology, including the development of new training opportunities and the establishment of substantive posts in clinical pharmacology.

Communications, Publications and Development

• Utilizetheopportunitiespresentedby thesubstantialfinancialsupport provided to the WorldPharma 2010 Congress, to enhance BPS relationships with overseas Societies, and to promote BPS membership and services to an international audience.

• LaunchanewBPSwebsitetogeneratean over-arching pharmacology portal, to promote pharmacology and clinical pharmacology to existing and potential members, other professional groups, and the general public, including school students, teachers and science communicators.

• Co-ordinatetheoperationsofthejournals,their single publisher and the Society’s other activities such as Meetings and Education to mutual advantage. Continue efforts to attract high quality papers to increase the impact factor of both journals.

• Enhancecommunicationwithmembers and other stakeholders via regular issues of Pharmacology Matters, highlighting topical issues and themed issues that will attract potential new members and inform the general public.

• ConductareviewofthecurrentSpecialInterest Groups, to determine whether they are an effective mechanism for facilitating two-way communication between the BPS its members and potential members.

• Inaugurateaworkingpartytolookattheneedsof members and potential members in the pharmaceutical industry, biotech and associated sectors and develop services to meet these needs as appropriate.

• Improvecommunicationwith,andservices for young people, including school students, undergraduates and post-graduates, via a variety of channels, including the continued development of social networking communities and enhanced website functionality.

• Developstrategiesforretainingexisting members and recruiting new members with a view to increasing the net membership during the year.

Policy Development

• Ensurethatpharmacologyandclinical pharmacology are fully represented in government and other agency consultations, working in conjunction with other learned societies when appropriate.

annual review and summarized accounts 2009€¦ · annual review, the decision was taken at the end...

Documents